DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
ONTARGET Investigators. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.
Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med 2008;
358: 1547-1559
We do not assume any responsibility for the contents of the web pages of other providers.